Work

A phase 2 study of ponatinib in patients (pts) with advanced gastrointestinal stromal tumors (GIST) after failure of tyrosine kinase inhibitor (TKI) therapy: Initial report.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10506

Authors: Michael C. Heinrich, Margaret vonMehren, George D. Demetri, Jonathan A. Fletcher, Jichao Sun, J. Graeme Hodgson, Victor M. Rivera, Christopher D. Turner, Suzanne George

Institutions: Oregon Health & Science University, Portland VA Medical Center, OHSU Knight Cancer Institute, Fox Chase Cancer Center, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, ARIAD Pharmaceuticals (United States)

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1845065486

Cites:

Cited by: 28

Related to: 10